Financial news in brief: Elixinol addresses funding concerns; Aurora growth helped by Australia; Avecho lifts cash, progresses trial; Cann receives NAB extension to finalise settlement; IRX reports lean quarter by Adam Sheldon November 4, 2025November 6, 2025 Elixinol was required to detail its funding position to the ASX after its September quarter filing […]
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
Elixinol Wellness secures A$2.5m to fund ‘reset strategy’ by Adam Sheldon September 8, 2025September 8, 2025
News in brief: Losses widen for Avecho and Elixinol; InhaleRx secures HREC approval; Zelira cuts deficit; Argent shifts from ‘non-core’ activities by Adam Sheldon August 29, 2025September 4, 2025
Financial news in brief: Elixinol reassures ASX over financing; NTI shuts down two subsidiaries by Steve Jones August 1, 2025August 1, 2025
Financial news in brief: Ecofibre looks to sell Ananda Health; product delays hit Elixinol by Steve Jones April 30, 2025April 30, 2025
Financial results: Elixinol Wellness; Rua Bioscience; Wellnex Life by Steve Jones March 3, 2025March 5, 2025
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024November 25, 2024
TGA to stick with 150mg dose of CBD amid Cann Group ‘surprise’ at UK advice by Steve Jones October 25, 2023April 30, 2024
